vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and RLI CORP (RLI). Click either name above to swap in a different company.

RLI CORP is the larger business by last-quarter revenue ($465.7M vs $270.8M, roughly 1.7× HUTCHMED (China) Ltd). RLI CORP runs the higher net margin — 19.6% vs 0.7%, a 18.9% gap on every dollar of revenue. On growth, RLI CORP posted the faster year-over-year revenue change (6.1% vs -16.5%). RLI CORP produced more free cash flow last quarter ($155.0M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

RLI Corp. is an American insurance company specializing in property insurance and casualty insurance. It is headquartered in Peoria, Illinois.

HCM vs RLI — Head-to-Head

Bigger by revenue
RLI
RLI
1.7× larger
RLI
$465.7M
$270.8M
HCM
Growing faster (revenue YoY)
RLI
RLI
+22.6% gap
RLI
6.1%
-16.5%
HCM
Higher net margin
RLI
RLI
18.9% more per $
RLI
19.6%
0.7%
HCM
More free cash flow
RLI
RLI
$151.6M more FCF
RLI
$155.0M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
RLI
RLI
Revenue
$270.8M
$465.7M
Net Profit
$2.0M
$91.2M
Gross Margin
37.7%
Operating Margin
-13.2%
24.4%
Net Margin
0.7%
19.6%
Revenue YoY
-16.5%
6.1%
Net Profit YoY
-83.6%
123.1%
EPS (diluted)
$0.00
$1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
RLI
RLI
Q4 25
$270.8M
$465.7M
Q3 25
$509.3M
Q2 25
$277.7M
$499.8M
Q1 25
$324.5M
$407.7M
Q4 24
$439.1M
Q3 24
$470.0M
Q2 24
$305.7M
$416.4M
Q1 24
$444.8M
Net Profit
HCM
HCM
RLI
RLI
Q4 25
$2.0M
$91.2M
Q3 25
$124.6M
Q2 25
$455.0M
$124.3M
Q1 25
$11.9M
$63.2M
Q4 24
$40.9M
Q3 24
$95.0M
Q2 24
$25.8M
$82.0M
Q1 24
$127.9M
Gross Margin
HCM
HCM
RLI
RLI
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
RLI
RLI
Q4 25
-13.2%
24.4%
Q3 25
30.9%
Q2 25
-1.3%
31.3%
Q1 25
-5.0%
19.3%
Q4 24
10.8%
Q3 24
24.9%
Q2 24
-9.0%
24.8%
Q1 24
36.0%
Net Margin
HCM
HCM
RLI
RLI
Q4 25
0.7%
19.6%
Q3 25
24.5%
Q2 25
163.8%
24.9%
Q1 25
3.7%
15.5%
Q4 24
9.3%
Q3 24
20.2%
Q2 24
8.4%
19.7%
Q1 24
28.8%
EPS (diluted)
HCM
HCM
RLI
RLI
Q4 25
$0.00
$1.00
Q3 25
$1.35
Q2 25
$0.52
$1.34
Q1 25
$0.01
$0.68
Q4 24
$-2.87
Q3 24
$2.06
Q2 24
$0.03
$1.78
Q1 24
$2.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
RLI
RLI
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.8B
Total Assets
$1.8B
$6.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
RLI
RLI
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Q1 24
Total Debt
HCM
HCM
RLI
RLI
Q4 25
$93.2M
Q3 25
$100.0M
Q2 25
$93.4M
$100.0M
Q1 25
$82.8M
$100.0M
Q4 24
$100.0M
Q3 24
$100.0M
Q2 24
$82.1M
$100.0M
Q1 24
$100.0M
Stockholders' Equity
HCM
HCM
RLI
RLI
Q4 25
$1.2B
$1.8B
Q3 25
$1.9B
Q2 25
$1.2B
$1.7B
Q1 25
$759.9M
$1.6B
Q4 24
$1.5B
Q3 24
$1.7B
Q2 24
$740.1M
$1.6B
Q1 24
$1.5B
Total Assets
HCM
HCM
RLI
RLI
Q4 25
$1.8B
$6.2B
Q3 25
$6.2B
Q2 25
$1.8B
$6.0B
Q1 25
$1.3B
$5.7B
Q4 24
$5.6B
Q3 24
$5.8B
Q2 24
$1.3B
$5.5B
Q1 24
$5.3B
Debt / Equity
HCM
HCM
RLI
RLI
Q4 25
0.08×
Q3 25
0.05×
Q2 25
0.08×
0.06×
Q1 25
0.11×
0.06×
Q4 24
0.07×
Q3 24
0.06×
Q2 24
0.11×
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
RLI
RLI
Operating Cash FlowLast quarter
$8.2M
$156.8M
Free Cash FlowOCF − Capex
$3.4M
$155.0M
FCF MarginFCF / Revenue
1.2%
33.3%
Capex IntensityCapex / Revenue
1.8%
0.4%
Cash ConversionOCF / Net Profit
4.21×
1.72×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$608.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
RLI
RLI
Q4 25
$8.2M
$156.8M
Q3 25
$179.2M
Q2 25
$-72.9M
$174.7M
Q1 25
$40.3M
$103.5M
Q4 24
$128.1M
Q3 24
$219.4M
Q2 24
$-39.8M
$141.8M
Q1 24
$70.9M
Free Cash Flow
HCM
HCM
RLI
RLI
Q4 25
$3.4M
$155.0M
Q3 25
$177.8M
Q2 25
$-82.2M
$173.4M
Q1 25
$32.5M
$102.5M
Q4 24
$127.6M
Q3 24
$219.0M
Q2 24
$-49.9M
$139.1M
Q1 24
$69.9M
FCF Margin
HCM
HCM
RLI
RLI
Q4 25
1.2%
33.3%
Q3 25
34.9%
Q2 25
-29.6%
34.7%
Q1 25
10.0%
25.1%
Q4 24
29.0%
Q3 24
46.6%
Q2 24
-16.3%
33.4%
Q1 24
15.7%
Capex Intensity
HCM
HCM
RLI
RLI
Q4 25
1.8%
0.4%
Q3 25
0.3%
Q2 25
3.3%
0.3%
Q1 25
2.4%
0.3%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
3.3%
0.7%
Q1 24
0.2%
Cash Conversion
HCM
HCM
RLI
RLI
Q4 25
4.21×
1.72×
Q3 25
1.44×
Q2 25
-0.16×
1.41×
Q1 25
3.38×
1.64×
Q4 24
3.13×
Q3 24
2.31×
Q2 24
-1.54×
1.73×
Q1 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

RLI
RLI

Casualty Segment$246.8M53%
Property Insurance Segment$122.5M26%
Other$59.3M13%
Surety Insurance Segment$37.1M8%

Related Comparisons